Clinical trial NCT05257447 - References

Pharmacokinetics — Pharmacokinetic and Bioequivalence Comparison of Baclofen and Chlorzoxazone Administered Individually or Concurrently

Citation(s)

•   Agarwal SK, Kriel RL, Cloyd JC, Coles LD, Scherkenbach LA, Tobin MH, Krach LE
  A pilot study assessing pharmacokinetics and tolerability of oral and intravenous baclofen in healthy adult volunteers. J Child Neurol. 2015 Jan;30(1):37-41. doi: 10.1177/0883073814535504. Epub 2014 Jul 14.
•   Court MH, Von Moltke LL, Shader RI, Greenblatt DJ
  Biotransformation of chlorzoxazone by hepatic microsomes from humans and ten other mammalian species. Biopharm Drug Dispos. 1997 Apr;18(3):213-26. doi: 10.1002/(sici)1099-081x(199704)18:33.0.co;2-0.
•   Ernstgard L, Warholm M, Johanson G
  Robustness of chlorzoxazone as an in vivo measure of cytochrome P450 2E1 activity. Br J Clin Pharmacol. 2004 Aug;58(2):190-200. doi: 10.1111/j.1365-2125.2004.02132.x.
•   Greenblatt DJ, Abourjaily PN
  Pharmacokinetics and Pharmacodynamics for Medical Students: A Proposed Course Outline. J Clin Pharmacol. 2016 Oct;56(10):1180-95. doi: 10.1002/jcph.732. Epub 2016 May 9. No abstract available.
•   He J, Li N, Xu J, Zhu J, Yu Y, Chen X, Lu Y
  An LC-MS/MS Validated Method for Quantification of Chlorzoxazone in Human Plasma and Its Application to a Bioequivalence Study. J Chromatogr Sci. 2019 Aug 16;57(8):751-757. doi: 10.1093/chromsci/bmz052.
•   He Q, Chhonker YS, McLaughlin MJ, Murry DJ
  Simultaneous Quantitation of S(+)- and R(-)-Baclofen and Its Metabolite in Human Plasma and Cerebrospinal Fluid using LC-APCI-MS/MS: An Application for Clinical Studies. Molecules. 2020 Jan 8;25(2):250. doi: 10.3390/molecules25020250.
•   Hohmann N, Blank A, Burhenne J, Suzuki Y, Mikus G, Haefeli WE
  Simultaneous phenotyping of CYP2E1 and CYP3A using oral chlorzoxazone and midazolam microdoses. Br J Clin Pharmacol. 2019 Oct;85(10):2310-2320. doi: 10.1111/bcp.14040. Epub 2019 Aug 9.
•   Johnson-Agbakwu C, Brown L, Yuan J, Kissling R, Greenblatt DJ
  Effects of Flibanserin on the Pharmacokinetics of a Combined Ethinylestradiol/Levonorgestrel Oral Contraceptive in Healthy Premenopausal Women: A Randomized Crossover Study. Clin Ther. 2018 Jan;40(1):64-73. doi: 10.1016/j.clinthera.2017.08.021. Epub 2017 Dec 2.
•   Lal R, Sukbuntherng J, Tai EH, Upadhyay S, Yao F, Warren MS, Luo W, Bu L, Nguyen S, Zamora J, Peng G, Dias T, Bao Y, Ludwikow M, Phan T, Scheuerman RA, Yan H, Gao M, Wu QQ, Annamalai T, Raillard SP, Koller K, Gallop MA, Cundy KC
  Arbaclofen placarbil, a novel R-baclofen prodrug: improved absorption, distribution, metabolism, and elimination properties compared with R-baclofen. J Pharmacol Exp Ther. 2009 Sep;330(3):911-21. doi: 10.1124/jpet.108.149773. Epub 2009 Jun 5.
•   Lucas D, Ferrara R, Gonzalez E, Bodenez P, Albores A, Manno M, Berthou F
  Chlorzoxazone, a selective probe for phenotyping CYP2E1 in humans. Pharmacogenetics. 1999 Jun;9(3):377-88. doi: 10.1097/00008571-199906000-00013.
•   Mishin VM, Rosman AS, Basu P, Kessova I, Oneta CM, Lieber CS
  Chlorzoxazone pharmacokinetics as a marker of hepatic cytochrome P4502E1 in humans. Am J Gastroenterol. 1998 Nov;93(11):2154-61. doi: 10.1111/j.1572-0241.1998.00612.x.
•   Noe DA
  Parameter Estimation and Reporting in Noncompartmental Analysis of Clinical Pharmacokinetic Data. Clin Pharmacol Drug Dev. 2020 Jul;9 Suppl 1:S5-S35. doi: 10.1002/cpdd.810.
•   Schmitz NS, Krach LE, Coles LD, Mishra U, Agarwal SK, Cloyd JC, Kriel RL
  A Randomized Dose Escalation Study of Intravenous Baclofen in Healthy Volunteers: Clinical Tolerance and Pharmacokinetics. PM R. 2017 Aug;9(8):743-750. doi: 10.1016/j.pmrj.2016.11.002. Epub 2016 Nov 17.
•   Simon N, Franchitto N, Rolland B
  Pharmacokinetic Studies of Baclofen Are Not Sufficient to Establish an Optimized Dosage for Management of Alcohol Disorder. Front Psychiatry. 2018 Oct 5;9:485. doi: 10.3389/fpsyt.2018.00485. eCollection 2018.
•   Streetman DS, Bertino JS Jr, Nafziger AN
  Phenotyping of drug-metabolizing enzymes in adults: a review of in-vivo cytochrome P450 phenotyping probes. Pharmacogenetics. 2000 Apr;10(3):187-216. doi: 10.1097/00008571-200004000-00001.
•   Valicherla GR, Mishra A, Lenkalapelly S, Jillela B, Francis FM, Rajagopalan L, Srivastava P
  Investigation of the inhibition of eight major human cytochrome P450 isozymes by a probe substrate cocktail in vitro with emphasis on CYP2E1. Xenobiotica. 2019 Dec;49(12):1396-1402. doi: 10.1080/00498254.2019.1581301. Epub 2019 Jun 19.
•   Vlavonou R, Perreault MM, Barriere O, Shink E, Tremblay PO, Larouche R, Pichette V, Tanguay M
  Pharmacokinetic characterization of baclofen in patients with chronic kidney disease: dose adjustment recommendations. J Clin Pharmacol. 2014 May;54(5):584-92. doi: 10.1002/jcph.247. Epub 2014 Jan 10.
•   Zhao Y, Harmatz JS, Epstein CR, Nakagawa Y, Kurosaki C, Nakamura T, Kadota T, Giesing D, Court MH, Greenblatt DJ
  Favipiravir inhibits acetaminophen sulfate formation but minimally affects systemic pharmacokinetics of acetaminophen. Br J Clin Pharmacol. 2015 Nov;80(5):1076-85. doi: 10.1111/bcp.12644. Epub 2015 Jun 8.

Pharmacokinetic and Bioequivalence Comparison of Baclofen and Chlorzoxazone When Administered Individually or Concurrently

Details for clinical trial NCT05257447